COMBI — Combigene AB Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro CapSucker Stock
- SEK142.96m
- SEK22.46m
- SEK26.70m
Annual balance sheet for Combigene AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | — | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 31.8 | 15.2 | 48.9 | 137 | 132 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.17 | 0.5 | 0.958 | 0.686 | 5.61 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 33.5 | 18.9 | 55.4 | 145 | 139 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 35.1 | 43.8 | 79.4 | 166 | 158 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 14.7 | 23.5 | 7.98 | 7.94 | 6.1 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 14.7 | 25.4 | 7.98 | 7.94 | 6.1 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Other Equity | |||||
| Total Equity | 20.5 | 18.5 | 71.4 | 158 | 152 |
| Total Liabilities & Shareholders' Equity | 35.1 | 43.8 | 79.4 | 166 | 158 |
| Total Common Shares Outstanding |